{"article": [{"url": "https://www.marketwatch.com/story/nn-inc-shares-soar-premarket-on-news-to-sell-life-sciences-division-in-825-million-deal-2020-08-24", "published": 1598259560.0, "headline": "NN Inc. shares soar premarket on news to sell life sciences division in $825 million deal", "body": "An earlier version of this report had a typo in the sum to be paid in an earnout in 2022. It has been corrected. Shares of diversified industrial company NN Inc. NNBR, -1.84% soared 37% in premarket trade Monday, after the company said it has agreed to sell its life sciences business of units of American Securities LLC in a deal worth $825 million. Under the terms of the deal, NN will receive $755 million on deal close, plus an additional $70 million in an earnout payable in cash based on the division's 2022 performance. The deal is expected to close in the fourth quarter. NN is planning to use the proceeds to pay down debt and bolster its balance sheet, reducing net leverage to about 1.8 times post transaction from about 6.1 times now. ?This is a pivotal moment for NN as the sale of Life Sciences provides us with a clear, expedient and certain path to obtain the necessary capital to significantly reduce our debt and continue to execute on our Power Solutions and Mobile Solutions businesses where we see strong potential to grow and generate value for our shareholders,\" Chief Executive Warren Veltman said in a statement. Shares have fallen 36% in the year through Friday, while the S&P 500 SPX, +0.87% has gained 5%."}]}